Estrogen modulation of apolipoprotein(a) expression - Identification of a regulatory element

被引:43
作者
Boffelli, D
Zajchowski, DA
Yang, ZY
Lawn, RM
机构
[1] Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Stanford, CA 94305 USA
[2] Berlex Biosci, Dept Canc Res, Richmond, CA 94804 USA
关键词
D O I
10.1074/jbc.274.22.15569
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elevated plasma levels of the lipoprotein particle Lp(a) are a major risk factor for cardiovascular disease, Lp(a) plasma levels are determined by the level of expression of its characteristic protein component, apo(a), Apo(a) expression is modulated by several hormones, of which estrogens are the best known, The chromosomal region responsible for estrogen response was identified within an apo(a) enhancer located at similar to 26 kilobases from the apo(a) promoter. Although the estrogen-responsive unit contains a potential estrogen response element, binding of estrogen receptor-cu to DNA was not necessary. The receptor, activated by bound estradiol, interacts through its transactivation domains with a transcription factor necessary for the function of the enhancer, preventing its binding to DNA.
引用
收藏
页码:15569 / 15574
页数:6
相关论文
共 55 条
[1]   Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) :1179-1184
[2]   Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1 [J].
Blobel, GA ;
Orkin, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (04) :1687-1694
[3]   APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS [J].
BOERWINKLE, E ;
LEFFERT, CC ;
LIN, JP ;
LACKNER, C ;
CHIESA, G ;
HOBBS, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :52-60
[4]   Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice [J].
Boonmark, NW ;
Lou, XJ ;
Yang, ZJ ;
Schwartz, K ;
Zhang, JL ;
Rubin, EM ;
Lawn, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :558-564
[5]   Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study [J].
Bostom, AG ;
Cupples, LA ;
Jenner, JL ;
Ordovas, JM ;
Seman, LJ ;
Wilson, PWF ;
Schaefer, EJ ;
Castelli, WP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :544-548
[6]   PLASMA-LIPID, LIPOPROTEIN CHOLESTEROL, AND APOPROTEIN DISTRIBUTIONS IN SELECTED UNITED-STATES COMMUNITIES - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].
BROWN, SA ;
HUTCHINSON, R ;
MORRISETT, J ;
BOERWINKLE, E ;
DAVIS, CE ;
GOTTO, AM ;
PATSCH, W .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1139-1158
[7]   THE HUMAN APOLIPOPROTEIN(A) PLASMINOGEN GENE-CLUSTER CONTAINS A NOVEL HOMOLOG TRANSCRIBED IN LIVER [J].
BYRNE, CD ;
SCHWARTZ, K ;
MEER, K ;
CHENG, JF ;
LAWN, RM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (04) :534-541
[8]   A 5' ELEMENT OF THE CHICKEN BETA-GLOBIN DOMAIN SERVES AS AN INSULATOR IN HUMAN ERYTHROID-CELLS AND PROTECTS AGAINST POSITION EFFECT IN DROSOPHILA [J].
CHUNG, JH ;
WHITELEY, M ;
FELSENFELD, G .
CELL, 1993, 74 (03) :505-514
[9]   SEQUENCE POLYMORPHISMS IN THE APOLIPOPROTEIN(A) GENE - EVIDENCE FOR DISSOCIATION BETWEEN APOLIPOPROTEIN(A) SIZE AND PLASMA LIPOPROTEIN(A) LEVELS [J].
COHEN, JC ;
CHIESA, G ;
HOBBS, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1630-1636
[10]  
Craig WY, 1998, CLIN CHEM, V44, P2301